Bendamustine, Carboplatin and Dexamethasone (BCD)

· Samsung Medical Center

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bendamustine, Carboplatin and Dexamethasone (BCD), covering 2018-09-06 to 2018-09-06. Get the full timeline:

Most recent: Clinical Trial Update: Bendamustine, Carboplatin and Dexamethasone (BCD) for Refractory or Relapsed Peripheral T-cell Lymphoma [Phase 2]